← Leaderboards
Admire Dube
University Of The Western Cape
$914,359
Attributed
$2,002,538
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $421.7K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,002,538 · 2
By mechanism
R01$1,632,268 · 1
K43$370,270 · 1
Top collaborators
- Joshua James Reineke5 shared
- Samantha Leigh Sampson5 shared
Others in their field
Other Emerging Leaders on “Research Personnel”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lynn Briscoe · Leidos Biomedical Research, Inc.$160,201,956
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$123,112,727
Research focus
Research PersonnelPharmaceutical PreparationsMultidrug-Resistant TuberculosisPublic HealthNanoparticlePathogenImmunotherapyImmunologyMacrophageKineticsMycobacterium TuberculosisNanomedicineAnimal ModelNanotechnologyCessation Of LifeAwardCommunicable DiseasesImmuneAntimicrobialInnovationBeta-GlucansInstitutionCellsResponse
Grant awards (10)
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$303,416
R01 · FY2024 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$318,225
R01 · FY2023 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$328,171
R01 · FY2022 · AI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$336,887
R01 · FY2021 · AI
Development of Nanomedicines for Tuberculosis Treatment$78,409
K43 · FY2021 · TW · contact PI
Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis$345,569
R01 · FY2020 · AI
Development of Nanomedicines for Tuberculosis Treatment$76,165
K43 · FY2020 · TW · contact PI
Development of Nanomedicines for Tuberculosis Treatment$73,808
K43 · FY2019 · TW · contact PI
Development of Nanomedicines for Tuberculosis Treatment$72,090
K43 · FY2018 · TW · contact PI
Development of Nanomedicines for Tuberculosis Treatment$69,798
K43 · FY2017 · TW · contact PI